249 related articles for article (PubMed ID: 23836876)
1. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions.
Luo J; Yablonskiy DA; Hildebolt CF; Lancia S; Cross AH
Mult Scler; 2014 Mar; 20(3):349-55. PubMed ID: 23836876
[TBL] [Abstract][Full Text] [Related]
2. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.
Sati P; Cross AH; Luo J; Hildebolt CF; Yablonskiy DA
Neuroimage; 2010 Jul; 51(3):1089-97. PubMed ID: 20338247
[TBL] [Abstract][Full Text] [Related]
3. Stronger Microstructural Damage Revealed in Multiple Sclerosis Lesions With Central Vein Sign by Quantitative Gradient Echo MRI.
Levasseur VA; Xiang B; Salter A; Yablonskiy DA; Cross AH
J Cent Nerv Syst Dis; 2022; 14():11795735221084842. PubMed ID: 35370433
[TBL] [Abstract][Full Text] [Related]
4. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
5. FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins.
Sati P; George IC; Shea CD; Gaitán MI; Reich DS
Radiology; 2012 Dec; 265(3):926-32. PubMed ID: 23074257
[TBL] [Abstract][Full Text] [Related]
6. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
7. Gradient echo plural contrast imaging--signal model and derived contrasts: T2*, T1, phase, SWI, T1f, FST2*and T2*-SWI.
Luo J; Jagadeesan BD; Cross AH; Yablonskiy DA
Neuroimage; 2012 Apr; 60(2):1073-82. PubMed ID: 22305993
[TBL] [Abstract][Full Text] [Related]
8. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures.
Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM
Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698
[TBL] [Abstract][Full Text] [Related]
9. Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.
Chen X; Schädelin S; Lu PJ; Ocampo-Pineda M; Weigel M; Barakovic M; Ruberte E; Cagol A; Marechal B; Kober T; Kuhle J; Kappos L; Melie-Garcia L; Granziera C
Neuroimage Clin; 2023; 37():103349. PubMed ID: 36801600
[TBL] [Abstract][Full Text] [Related]
10. Fast whole-brain three-dimensional macromolecular proton fraction mapping in multiple sclerosis.
Yarnykh VL; Bowen JD; Samsonov A; Repovic P; Mayadev A; Qian P; Gangadharan B; Keogh BP; Maravilla KR; Jung Henson LK
Radiology; 2015 Jan; 274(1):210-20. PubMed ID: 25208343
[TBL] [Abstract][Full Text] [Related]
11. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
Filippi M; Preziosa P; Pagani E; Copetti M; Mesaros S; Colombo B; Horsfield MA; Falini A; Comi G; Lassmann H; Rocca MA
Mult Scler; 2013 Apr; 19(4):418-26. PubMed ID: 22907944
[TBL] [Abstract][Full Text] [Related]
12. Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Mistry N; Abdel-Fahim R; Mougin O; Tench C; Gowland P; Evangelou N
Mult Scler; 2014 Feb; 20(2):227-33. PubMed ID: 23858017
[TBL] [Abstract][Full Text] [Related]
13. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI.
Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672
[TBL] [Abstract][Full Text] [Related]
14. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.
Sampat MP; Berger AM; Healy BC; Hildenbrand P; Vass J; Meier DS; Chitnis T; Weiner HL; Bakshi R; Guttmann CR
AJNR Am J Neuroradiol; 2009 Oct; 30(9):1731-9. PubMed ID: 19696139
[TBL] [Abstract][Full Text] [Related]
15. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
Rudick RA; Lee JC; Nakamura K; Fisher E
J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
[TBL] [Abstract][Full Text] [Related]
16. Assessing the correlation between grey and white matter damage with motor and cognitive impairment in multiple sclerosis patients.
Sbardella E; Petsas N; Tona F; Prosperini L; Raz E; Pace G; Pozzilli C; Pantano P
PLoS One; 2013; 8(5):e63250. PubMed ID: 23696802
[TBL] [Abstract][Full Text] [Related]
17. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
[TBL] [Abstract][Full Text] [Related]
18. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
19. Gray matter atrophy in multiple sclerosis: a longitudinal study.
Fisher E; Lee JC; Nakamura K; Rudick RA
Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
[TBL] [Abstract][Full Text] [Related]
20. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis?
Campion T; Smith RJP; Altmann DR; Brito GC; Turner BP; Evanson J; George IC; Sati P; Reich DS; Miquel ME; Schmierer K
Eur Radiol; 2017 Oct; 27(10):4257-4263. PubMed ID: 28409356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
